CNBX PHARMACEUTICALS INC. Other General Expense
CNBX PHARMACEUTICALS INC. (CNBX) reported Other General Expense of $40.45 thousand for the 12-month period ending 2025-08-31, per its 10-K filed 2025-12-01.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherGeneralExpense · last filed 2025-12-01
- CNBX PHARMACEUTICALS INC. other general expense for fiscal 2025 was $40.45K, a 24.50% decline from fiscal 2024.
- CNBX PHARMACEUTICALS INC. other general expense for fiscal 2024 was $53.57K, a 8.19% increase from fiscal 2023.
- CNBX PHARMACEUTICALS INC. other general expense for fiscal 2023 was $49.52K, a 64.41% decline from fiscal 2022.
- CNBX PHARMACEUTICALS INC. other general expense for fiscal 2022 was $139.14K, a 59.11% increase from fiscal 2021.
| Period end | Other General Expense 12 month | Other General Expense 12 month as first filed |
|---|---|---|
| 2025-08-31 | $40.45K 10-K · filed 2025-12-01 | |
| 2024-08-31 | $53.57K 10-K · filed 2025-12-01 | |
| 2023-08-31 | $49.52K 10-K · filed 2024-11-29 | |
| 2022-08-31 | $139.14K 10-K · filed 2023-11-30 | $109.18K 10-K · filed 2022-11-30 |
| 2021-08-31 | $87.45K 10-K · filed 2022-11-30 | |
| 2020-08-31 | $84.05K 10-K · filed 2021-11-29 | |
| 2019-08-31 | $329.21K 10-K · filed 2020-11-04 | |
| 2018-08-31 | $106.44K 10-K · filed 2019-11-29 | |
| 2017-08-31 | $97.69K 10-K · filed 2018-11-29 | $133.64K 10-K · filed 2017-12-08 |
| 2016-08-31 | $43.84K 10-K · filed 2017-12-08 |